MedPath

The effect of oral and sublingual and buccal Misoprostol on induction of preterm premature rupture of membrane

Phase 3
Conditions
Preterm premature rupture of the membranes.
Premature rupture of membranes
Registration Number
IRCT20190410043237N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
120
Inclusion Criteria

women with single pregnancy
preterm premature rupture of membrane
gestational age of 37-42 weeks
cephalic presentation
informed consent of the individual to enter the study
low risk pregnancy (no complications such as preeclampsia and gestational diabetes and heart diseases)
satisfactory fetal heart rate patterns
absence of contraindication to natural childbirth and no history of uterine scar
bishop score of less than 6

Exclusion Criteria

onset of uterine contractions
symptoms of chorioamnionitis
fetal macrosomia
use of other methods of initiating induction within the last 7 days

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The interval between initiation of induction and delivery. Timepoint: after the intervention. Method of measurement: patient's file.
Secondary Outcome Measures
NameTimeMethod
atural delivery or cesarean section. Timepoint: after the intervention. Method of measurement: based on file.;Investigation of Misoprostol side-effects. Timepoint: after medication use. Method of measurement: based on clinical observations.;Investigation of maternal complications such as postpartum hemorrhage. Timepoint: after delivery. Method of measurement: based on clinical observations.;Investigation of neonatal complications such as Apgar Score, dystocia, ICU hospitalization , Sepsis and bacteremia. Timepoint: Immediately after the birth of the infant. Method of measurement: based on clinical observations.
© Copyright 2025. All Rights Reserved by MedPath